UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, D.C. 20549

~~_______________________________~~__________________

FORM 8-K

~~_______________________________~~__________________

CURRENT REPORT

Pursuant to Section 13 orOR 15(d) ~~of the Securities Exchange Act of 1934~~

~~Date~~ of ~~Report~~the ~~(Date~~Securities ofExchange ~~Earliest~~Act ~~Event~~of ~~Reported): May 7, 2025~~1934

~~_____________________________~~June 13, 2025

Date of Report (Date of Earliest Event Reported)

__________________

Endo, Inc.

(Exact name of registrant as specified in its charter)

~~_______________________________~~__________________

Delaware	333-280767	30-1390281	~~333-280767~~	~~30-1390281~~
(State or other jurisdictionof incorporation)			(Commission File Number)	(IRS EmployerIdentification No.)
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

9 Great Valley Parkway
Malvern,	Pennsylvania	19355
(Address of principal executive offices)		(Zip Code)

9 Great Valley Parkway, Malvern, Pennsylvania 19355

~~Registrant's~~(Address ~~telephone~~of ~~number,~~principal ~~including~~executive ~~area~~offices) ~~code 484-216-0000~~ (Zip Code)

~~Not~~Registrant’s ~~Applicable~~telephone number, including area code: +1 (484) 216-0000

~~(Former name or former address, if changed since last report.)~~__________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None ~~(1)~~

~~(1)~~Indicate Onby ~~June~~check ~~28,~~mark ~~2024,~~whether ~~Endo,~~the ~~Inc.~~registrant ~~common~~is ~~stock~~an ~~was~~emerging ~~quoted~~growth company ~~and~~as ~~began~~defined ~~trading~~in onRule 405 of the ~~OTCQX®~~Securities ~~Best~~Act ~~Market~~of ~~under~~1933 (§ 230.405 of this chapter) or Rule 12b-2 of the ~~symbol~~Securities ~~“NDOI~~Exchange Act of 1934 (§ 240.”12b-2 of this chapter).

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐

Emerging growth company

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2 5.~~02. Results~~07 Submission of ~~Operations~~Matters ~~and~~to ~~Financial~~a ~~Condition~~Vote of Security Holders.

On ~~May 7~~June 13, 2025, Endo, Inc., a Delaware corporation (“Endo”), convened a special meeting of stockholders (the “~~Company,~~Special Meeting”) ~~“Endo~~to consider and vote upon certain proposals related to the Transaction Agreement,” dated March 13, 2025 (as further amended, modified, restated or supplemented from time to time, the “weTransaction Agreement”), ~~issued~~with Mallinckrodt plc, an ~~earnings~~Irish ~~release~~public ~~announcing~~limited ~~its~~company ~~financial~~(“Mallinckrodt”), ~~results~~and Salvare Merger Sub LLC, a Delaware limited liability company and a wholly owned subsidiary of Mallinckrodt (“Merger Sub”), providing for, among other things, (a) the ~~three~~memorandum ~~months~~and ~~ended~~articles ~~March~~of 31association of Mallinckrodt will be amended by means of a scheme of arrangement (the “Articles Scheme Amendment”) under the Companies Act 2014 and shareholder approval; (b) the memorandum and articles of association of Mallinckrodt will be further amended by shareholder approval following the Articles Scheme Amendment (together with the Articles Scheme Amendment, the ~~2025~~“Articles Amendments”); and (c) Merger Sub will merge with and into Endo (such merger, the “~~Earnings~~business ~~Release~~combination” and, together with the Articles Amendments, the “Transaction”), with Endo surviving the business combination as a wholly owned subsidiary of Mallinckrodt. AAs ~~copy~~a result of the ~~Earnings~~business ~~Release~~combination, isEndo ~~attached~~will asno ~~Exhibit~~longer 99be publicly held.1 ~~hereto~~Endo’s common stock will be delisted from the OTCQX® Best Market and isderegistered ~~incorporated~~under ~~herein~~the bySecurities ~~reference~~Exchange Act of 1934, as amended.

~~The~~There ~~Company~~were ~~utilizes~~76,313,462 ~~certain~~shares ~~financial~~of ~~measures~~common ~~that~~stock, par ~~are~~value ~~not~~$0.001 ~~prescribed~~per byshare, orof ~~prepared~~Endo ~~in accordance with accounting principles generally accepted in~~ (the ~~U.S. (~~“~~GAAP”).~~Endo ~~The~~common ~~Company utilizes these financial measures~~stock”), ~~commonly~~issued ~~referred~~and tooutstanding as ~~“non-GAAP,”~~of asApril ~~supplements~~29, to2025, ~~financial~~the ~~measures~~record ~~determined~~date for inthe ~~accordance~~Special ~~with~~Meeting ~~GAAP~~(the ~~when~~“Record ~~evaluating~~Date”). At the ~~Company’s~~Special ~~operating~~Meeting, ~~performance and~~ the ~~Company~~holders ~~believes~~of ~~that~~61,881,572 ~~they~~shares ~~will~~of beEndo ~~used~~common bystock were ~~certain~~present ~~investors~~or torepresented ~~measure~~by ~~the~~proxy, ~~Company’s~~representing ~~operating~~approximately ~~results~~81.09% ~~The~~of ~~Company~~the ~~believes~~total ~~that~~outstanding ~~presenting~~shares ~~these~~of ~~non-GAAP~~Endo ~~financial~~common ~~measures~~stock ~~provides~~as ~~useful~~of ~~information about~~ the Record ~~Company’s performance across reporting periods on a consistent basis by excluding certain items~~Date, which ~~may~~constituted bea ~~favorable or unfavorable~~quorum.

~~These~~At ~~non-GAAP~~the ~~financial~~Special ~~measures~~Meeting, ~~should~~the befollowing ~~considered~~proposals were ~~supplemental~~voted toupon ~~and~~(each ~~not~~of awhich ~~substitute~~is ~~for~~described ~~financial~~in ~~information~~greater ~~prepared~~detail in ~~accordance~~the ~~with~~definitive ~~GAAP.~~proxy ~~The~~statement ~~Company’s~~filed ~~definition of these non-GAAP financial measures may differ from similarly titled measures used~~ by ~~others.~~Endo ~~The~~with ~~definitions of~~ the ~~most~~Securities ~~commonly~~and Exchange ~~used~~Commission ~~non-GAAP~~on ~~financial~~May ~~measures~~12, ~~are~~2025 ~~presented~~(the ~~below.~~“Proxy Statement”)):

~~Adjusted~~Proposal ~~net~~1 ~~income~~– Transaction Proposal: Proposal to approve and adopt the Transaction Agreement, ~~Adjusted~~including ~~Gross~~the ~~Profit~~plan of merger contained therein, and ~~Adjusted~~the ~~Operating~~transactions contemplated ~~Expenses~~thereby, including the business combination, and the other transactions contemplated by the Transaction Agreement (the “Transaction Proposal”).

~~Adjusted~~Proposal ~~net~~2 ~~income,~~– ~~Adjusted~~Distributable Reserves ~~Gross~~Proposal: ~~Profit~~Proposal ~~and~~to ~~Adjusted~~approve, ~~Operating~~on ~~Expenses~~a ~~are~~non-binding, ~~presented~~advisory asbasis, ~~non-GAAP~~(i) ~~measures~~the ~~and~~reduction ~~are~~of ~~reconciled~~the toentire ~~their~~amount ~~corresponding~~(or ~~GAAP~~such ~~measures~~lesser amount as the directors of ~~Net~~Mallinckrodt ~~income~~or ~~(loss),~~the ~~Gross~~Irish ~~Profit,~~High ~~defined~~Court asmay ~~revenues~~determine) ~~less~~standing ~~cost~~to ofthe ~~revenues,~~credit ~~and~~of ~~Operating~~Mallinckrodt’s ~~Expenses,~~share ~~defined~~premium account as at the ~~sum~~date of the joint proxy statement/prospectus (i)being ~~Selling,~~the ~~general~~first ~~and~~Mallinckrodt ~~administrative~~distributable reserves creation); and (ii) ~~Research~~the ~~and~~reduction of ~~development;~~the entire amount (~~iii)~~or ~~Acquired~~such ~~in-process~~lesser ~~research~~amount ~~and~~as ~~development;~~the ~~(iv)~~directors ~~Litigation-related~~of ~~and~~Mallinckrodt ~~other~~or ~~contingencies,~~the ~~net;~~Irish (vHigh Court may determine) ~~Asset~~standing ~~impairment~~to ~~charges;~~the ~~and~~credit of ~~(vi)~~Mallinckrodt’s ~~Acquisition~~share ~~related~~premium ~~and~~account ~~integration~~following ~~items~~the consummation of the business combination, ~~net~~(including but not limited to the share premium arising from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement or the amounts credited to Mallinckrodt’s share premium account upon the capitalization of any merger reserve or like reserve resulting from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement) (the “Distributable Reserves Proposal”).

~~Adjustments,~~Proposal to3 ~~the~~– ~~extent~~Combination-Related Compensation ~~they~~Proposal: ~~apply~~Proposal to ~~the corresponding GAAP amounts~~approve, ~~may~~on ~~include,~~a ~~but are not limited to expense or income related to: acquisitions and divestitures, such as amortization of intangible assets and of inventory step~~non-~~up adjustments~~binding, ~~certain~~advisory ~~employee-related charges~~basis, ~~including~~the ~~earn-outs,~~compensation ~~separation,~~that ~~retention,~~will or ~~relocation~~may ~~costs,~~become ~~changes~~payable inby Endo ~~the fair value of contingent consideration, transaction costs of executed deals, and integration~~ or ~~disintegration-related~~its ~~costs;~~subsidiaries ~~certain amounts related~~ to ~~strategic~~its ~~review~~named ~~initiatives;~~executive ~~certain~~officers ~~cost reduction initiatives such as separation benefits, continuity payments, other exit costs; asset impairment charges; certain costs incurred~~ in connection with ~~debt~~the orconsummation equity-financing activities, such as non-capitalizable transaction costs incurred in connection with a successful financing transaction and gains or losses associated with early repayments, extinguishment or modification of ~~our debt instruments; litigation-related and other contingent matters; certain legal costs; gains or losses from~~ the ~~sales~~Transaction ~~of businesses and other assets; gains or losses associated with discontinued operations, net of tax; foreign currency gains or losses on intercompany financing arrangements; reorganization items, net;~~ (the ~~tax effect of adjusted pre~~“Combination-~~tax~~Related Compensation ~~income at applicable tax rates and other tax adjustments; and certain other items~~Proposal”).

~~Adjusted~~Proposal ~~gross~~4 ~~margin~~– &Mallinckrodt Articles ~~Adjusted~~Amendment ~~operating~~Proposals: ~~expenses~~Proposals to approve, on a non-binding, advisory basis, eight proposed amendments to the Mallinckrodt articles of association, presented separately in accordance with the requirements of the United States Securities and Exchange Commission (collectively, the “Mallinckrodt Articles Amendment Proposals”):

~~Adjusted~~(a) ~~gross~~to ~~margin~~vary ~~represents total revenues less cost of revenues prepared in accordance with GAAP and adjusted for~~ the ~~certain~~authorized ~~items~~share ~~enumerated~~capital ~~above under the heading “Adjusted net income” to the extent such items relate to cost~~ of ~~revenues. Such items may include~~Mallinckrodt, ~~but~~including ~~are~~through ~~not~~the ~~limited~~creation ~~to, expenses or income related to: acquisitions and divestitures, such as amortization~~ of ~~intangible~~a ~~assets~~new ~~and~~class of ~~inventory~~preferred ~~step-up adjustments~~shares, ~~certain~~the ~~employee-related~~removal ~~charges,~~of ~~including earn~~pre-~~outs,~~emption ~~separation,~~rights ~~retention,~~of ~~or relocation costs,~~ certain ~~amounts~~shareholders ~~related~~over tonewly ~~strategic~~issued ~~review~~shares ~~initiatives;~~and ~~certain~~the ~~cost~~deletion ~~reduction~~of ~~initiatives~~Article ~~such~~174 asof ~~separation~~the ~~benefits,~~existing ~~continuity~~Mallinckrodt ~~payments~~constitution, ~~contract~~which ~~termination~~capped ~~costs~~the ~~and~~total ~~other~~number ~~exit~~of ~~costs;~~shares ~~certain~~issuable ~~integration~~pursuant ~~or disintegration efforts; certain amounts related~~ to ~~strategic~~Mallinckrodt’s ~~review~~management ~~initiatives;~~incentive ~~amortization~~plan ofat ~~intangible assets and of inventory step-up adjustments~~10%; ~~and certain other items.~~

~~Adjusted~~(b) ~~operating~~to ~~expenses~~delete certain restrictions on Mallinckrodt shareholders’ ability to deal in their Mallinckrodt shares, amend the circumstances in which directors can decline to register a transfer of shares and eliminate the drag-along rights and tag-along rights in the existing memorandum and articles of association of Mallinckrodt;

~~Adjusted~~(c) ~~operating~~to ~~expenses~~change ~~represent~~the ~~operating~~quorum ~~expenses~~required ~~prepared in accordance with GAAP and adjusted~~ for ~~certain items~~general ~~enumerated~~meetings ~~above under the heading “Adjusted net income”~~ (to ~~the~~two ~~extent such items relate to operating expenses. Such items may include, but are not limited to expenses~~ or ~~income~~more ~~related~~persons ~~to:~~holding ~~acquisitions and divestitures, such as certain employee-related charges, including earn-outs, separation, retention,~~ (or ~~relocation~~representing ~~costs,~~by ~~transaction~~proxy) ~~costs~~at ~~and~~least ~~changes~~one half in ~~the~~nominal ~~fair~~ value of ~~contingent~~the ~~consideration;~~issued ~~cost~~shares ~~reduction~~of ~~and~~an ~~integration-related~~applicable ~~initiatives such as separation benefits~~class), ~~continuity~~the ~~payments,~~manner ~~other~~in ~~exit~~which ~~costs;~~voting ~~certain~~will ~~integration~~be orconducted ~~disintegration~~(by ~~efforts;~~requiring ~~certain~~voting ~~amounts related~~ to ~~strategic~~be ~~review~~carried ~~initiatives;~~out ~~asset~~by ~~impairment~~way ~~charges; amortization~~ of ~~intangible~~a ~~assets;~~poll) ~~inventory step-up recorded as part of our acquisitions; litigation-related~~ and ~~other~~the ~~contingent~~procedures ~~matters;~~required ~~certain~~for ~~legal~~advance ~~costs;~~notice ~~certain~~of ~~costs~~members’ ~~incurred~~business ~~in connection with debt or equity-financing activities, such as non-capitalizable transaction costs incurred in connection with a successful financing transaction~~ and ~~gains~~nominations or(by ~~losses~~aligning ~~associated~~ with ~~early~~the ~~repayments,~~customary ~~extinguishment~~current orapproach ~~modification~~by ofU.S. ~~our~~listed ~~debt instruments~~companies); ~~and certain other items.~~

~~Adjusted~~(d) ~~income~~to ~~taxes~~delete the ability of holders of more than one half of the Mallinckrodt shares to require the Mallinckrodt board to initiate a process for a review of strategic alternatives and ~~Adjusted~~a ~~effective~~sale ~~tax~~of ~~rate~~assets or business segments, to delete restrictions on the Mallinckrodt board from selling, leasing or exchanging all or substantially all of Mallinckrodt’s property and assets without prior consent of the holders of more than one half of the Mallinckrodt shares, to amend provisions regarding shareholder rights plan to align with the customary approach adopted by Irish incorporated U.S. listed companies and to restrict Mallinckrodt from engaging in business combinations with “interested members” for a period of time;

~~Adjusted~~(e) ~~income~~to ~~taxes~~permit ~~are calculated by tax effecting adjusted pre-tax income and permanent book-tax differences at~~ the ~~applicable~~Mallinckrodt ~~effective~~board ~~tax~~to ~~rate~~determine ~~that~~its ~~will~~own besize ~~determined~~(subject ~~by reference~~ to ~~statutory~~a ~~tax~~minimum ~~rates~~of intwo ~~the relevant jurisdictions in which the Company operates. Adjusted income taxes include current~~ and ~~deferred~~a ~~income~~maximum ~~tax expense commensurate with the non-GAAP measure~~ of ~~profitability.~~twenty ~~Adjustments~~directors) ~~are~~and ~~then~~its ~~made~~own ~~for~~chair, ~~certain~~and ~~items relating~~ to ~~prior~~allow ~~years and~~ for ~~tax planning actions that are expected to be distortive to~~ the ~~underlying~~vacation ~~effective~~ipso ~~tax~~facto ~~rate~~of ~~and trend in~~ the ~~effective~~office ~~tax~~of ~~rate.~~a ~~The~~director ~~most~~where ~~directly~~he ~~comparable~~or ~~GAAP~~she ~~financial measure for Adjusted income taxes~~ is ~~Income~~requested ~~tax~~to ~~expense~~resign ~~(benefit), prepared~~ in ~~accordance~~writing ~~with~~by ~~GAAP.~~not ~~The~~less ~~Adjusted~~than ~~effective~~three ~~tax~~quarters ~~rate~~of ~~represents~~ the ~~rate~~other ~~generated when dividing Adjusted income taxes by the amount of adjusted pre-tax income.~~directors;

~~EBITDA~~(f) to change the provisions regarding appointment of Mallinckrodt directors and ~~Adjusted~~add ~~EBITDA~~provisions regarding plurality voting of directors;

~~EBITDA represents Net income~~ (~~loss~~g) ~~before~~to ~~Interest~~delete ~~expense,~~existing ~~net;~~provisions ~~Income tax expense; Depreciation; and Amortization, each prepared~~ in ~~accordance~~respect ~~with~~of ~~GAAP.~~information ~~Adjusted~~rights ~~EBITDA~~and ~~further~~board ~~adjusts~~observers ~~EBITDA~~for bycertain ~~excluding~~shareholders; ~~those items enumerated above under the heading “Adjusted net income,” without duplication,~~ and ~~stock-based compensation costs.~~

~~Because~~(h) ~~adjusted~~to ~~financial~~make ~~measures~~certain ~~exclude~~other ~~the~~changes ~~effect of items that will increase or decrease the Company’s reported results of operations, the Company strongly encourages investors~~ to ~~review~~make ~~the Company~~Mallinckrodt’s ~~consolidated~~articles ~~financial statements and publicly filed reports in their entirety. Investors are also encouraged to review the reconciliation~~ of ~~the~~association ~~non-GAAP financial measures used~~ in ~~the~~a ~~Earnings~~form ~~Release~~that tois ~~their~~customary ~~most~~for ~~directly~~an ~~comparable~~Irish ~~GAAP~~public ~~financial~~limited ~~measures~~company aseffecting ~~included~~a intransaction ~~the~~of ~~Earnings Release. However,~~ the ~~Company~~nature ~~does not provide reconciliations~~ of projected non-GAAP financial measures to GAAP financial measures, nor does it provide comparable projected GAAP financial measures for such projected non-GAAP financial measures. The Company is unable to provide such reconciliations without unreasonable efforts due to the ~~inherent~~Transaction ~~difficulty in forecasting~~ and ~~quantifying certain amounts that are necessary~~ for ~~such~~a ~~reconciliations,~~potential ~~including~~listing ~~adjustments~~of ~~that~~Mallinckrodt’s ~~could~~shares ~~be made for asset impairments, contingent consideration adjustments, legal settlements, gains or losses~~ on ~~extinguishment or modification of debt, adjustments to inventory and other charges reflected in~~ the ~~reconciliation~~New ofYork ~~historic~~Stock ~~numbers, the amount of which could be significant~~Exchange.

~~The~~Each ~~information~~proposal inwas ~~this~~approved ~~Item~~by ~~2.02 and in Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of~~ the ~~Securities~~requisite vote ~~Exchange Act~~ of ~~1934,~~Endo’s ~~as amended, or otherwise subject to the liabilities of that section~~stockholders. The ~~information~~final ~~contained~~voting inresults ~~this~~for ~~Item~~each ~~2.02~~proposal ~~and~~are indescribed ~~Exhibit 99~~below.1 ~~attached~~For ~~hereto~~more ~~shall~~information ~~not~~on beeach ~~incorporated into any registration statement or other document filed by the Registrant with the U.S. Securities and Exchange Commission under the Securities Act~~ of ~~1933~~these proposals, ~~whether~~see ~~made before or after~~ the ~~date~~Proxy ~~hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing~~Statement.

~~Item~~Proposal ~~5.02~~1 ~~Departure~~– ofTransaction ~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~Proposal

On May 6, 2025, Patrick A. Barry, Executive Vice President, President Global Commercial Operations, notified the Company of his intent to resign, effective as of May 30, 2025, in order to accept a position with another company. Mr. Barry will not receive any severance payments or benefits in connection with his resignation .

Votes For		Votes Against		Abstentions
61,792,120		89,452		0

~~Item~~Proposal ~~8.01~~2 ~~Other~~– ~~Events.~~Distributable Reserves Proposal

Endo intends to hold its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on June 25, 2025. The record date for the Annual Meeting is May 14, 2025. The time and location of the Annual Meeting will be specified in the Company’s upcoming definitive proxy statement related to the Annual Meeting.

Votes For		Votes Against		Abstentions
61,792,120		89,452		0

~~The~~Proposal ~~Company~~3 ~~has~~– ~~set May 13, 2025 as the deadline for submitting a stockholder proposal for inclusion in the Company’s proxy materials for the Annual Meeting pursuant to Rule 14a~~Combination-8Related Compensation under the Securities Exchange Act of 1934, as amended. Accordingly, in order for a stockholder proposal to be considered timely for inclusion in the Company’s proxy materials for the Annual Meeting, the proposal must be received by the Secretary of the Company at the Company’s principal executive offices at 9 Great Valley Parkway, Malvern, Pennsylvania 19355, no later than the close of business on such date, and comply with the procedures and requirements set forth in Rule 14a-8.Proposal

In accordance with the advance notice requirements contained in the Amended and Restated Bylaws of the Company (the “Bylaws”), for director nominations or other business to be brought before the Annual Meeting by a stockholder, other than Rule 14a-8 proposals described above, written notice to the Secretary of the Company must be delivered to the Company’s principal executive offices no later than the close of business on May 17, 2025. Any such notices must comply with the requirements of the Bylaws.

Votes For		Votes Against		Abstentions
61,772,299		108,528		745

~~Item~~Proposal ~~9.01. Financial~~4 ~~Statements~~– ~~and~~Mallinckrodt ~~Exhibits.~~Articles Amendment Proposals

Proposal 4(da) ~~Exhibits.~~

Number		Description
Votes For	Votes Against		Abstentions
99.1		Press Release
47,253,335	14,626,367		1,870
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

~~SIGNATURES~~Proposal 4(b)

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Votes For		Votes Against		Abstentions
50,020,164		11,859,538		1,870

~~ENDO,~~Proposal ~~INC. By: /s/ Matthew J. Maletta Name: Matthew J. Maletta Title: Executive Vice President,Chief Legal Officer and Secretary~~4(c)

Dated: May 7, 2025

Votes For		Votes Against		Abstentions
50,023,073		11,856,629		1,870

Proposal 4(d)

Votes For		Votes Against		Abstentions
46,139,932		15,739,770		1,870

Proposal 4(e)

Votes For		Votes Against		Abstentions
50,010,137		11,868,820		2,615

Proposal 4(f)

Votes For		Votes Against		Abstentions
50,023,073		11,856,629		1,870

Proposal 4(g)

Votes For		Votes Against		Abstentions
50,022,328		11,856,629		2,615

Proposal 4(h)

Votes For		Votes Against		Abstentions
50,023,073		11,856,629		1,870

Item 8.01 Other Events.

On June 13, 2025, Endo issued a joint press release with Mallinckrodt announcing the results of their respective special meetings of shareholders. A copy of the joint press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number	Description
99.1	Joint Press Release, dated June 13, 2025.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ENDO, INC.


Date: June 13, 2025	By:	/s/ Matthew J. Maletta
	Name:	Matthew J. Maletta
	Title:	Executive Vice President, Chief Legal Officer and Secretary

Filing Compare · Endo LP